Martha Blaney

2.4k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Martha Blaney is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Martha Blaney has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Martha Blaney's work include Central Venous Catheters and Hemodialysis (11 papers), Acute Myocardial Infarction Research (8 papers) and Advanced Breast Cancer Therapies (8 papers). Martha Blaney is often cited by papers focused on Central Venous Catheters and Hemodialysis (11 papers), Acute Myocardial Infarction Research (8 papers) and Advanced Breast Cancer Therapies (8 papers). Martha Blaney collaborates with scholars based in United States, Spain and Canada. Martha Blaney's co-authors include Harlan M. Krumholz, Robert L. McNamara, Elizabeth H. Bradley, David J. Magid, Jeph Herrin, Yongfei Wang, Jeptha P. Curtis, Frederick A. Spencer, Eric D. Peterson and Edward L. Portnay and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Martha Blaney

45 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Door-to-Balloon Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction

2006 589 citations Robert L. McNamara, Yongfei Wang et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martha Blaney United States	14	1.1k	507	358	329	244	45	1.7k
Melissa Forgie Canada	11	939 0.8×	106 0.2×	279 0.8×	752 2.3×	199 0.8×	16	2.8k
Alan S. Go United States	10	1.5k 1.4×	189 0.4×	523 1.5×	476 1.4×	82 0.3×	14	2.0k
Marek Gierlotka Poland	26	1.8k 1.6×	223 0.4×	660 1.8×	1.0k 3.1×	267 1.1×	216	2.6k
William C. Nugent United States	20	731 0.7×	99 0.2×	111 0.3×	516 1.6×	270 1.1×	49	1.5k
Mashio Nakamura Japan	28	2.2k 2.0×	110 0.2×	167 0.5×	851 2.6×	481 2.0×	151	3.6k
Leif Spange Mortensen Denmark	27	2.6k 2.3×	277 0.5×	686 1.9×	830 2.5×	168 0.7×	57	3.3k
Tracy L. Schifftner United States	15	462 0.4×	288 0.6×	38 0.1×	917 2.8×	202 0.8×	19	1.6k
Zbigniew Siudak Poland	24	1.5k 1.4×	136 0.3×	571 1.6×	986 3.0×	414 1.7×	205	2.1k
Richard S. D’Agostino United States	27	2.0k 1.8×	168 0.3×	188 0.5×	1.3k 3.8×	1.1k 4.5×	50	2.9k
Andrew Archbold United Kingdom	21	1.1k 0.9×	118 0.2×	204 0.6×	613 1.9×	270 1.1×	55	1.6k

Countries citing papers authored by Martha Blaney

Since Specialization

Citations

This map shows the geographic impact of Martha Blaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Blaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Blaney more than expected).

Fields of papers citing papers by Martha Blaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Blaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Blaney. The network helps show where Martha Blaney may publish in the future.

Co-authorship network of co-authors of Martha Blaney

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Blaney. A scholar is included among the top collaborators of Martha Blaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Blaney. Martha Blaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Toshio, John D. Powderly, Albiruni Abdul Razak, et al.. (2024). First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors. Frontiers in Oncology. 14. 1376551–1376551. 4 indexed citations

Strickler, John H., François Ghiringhelli, Jonathan Cohen, et al.. (2024). 1439P ABBV-400, a c-Met protein–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced gastric/gastroesophageal junction adenocarcinoma (GEA): Results from a phase I study. Annals of Oncology. 35. S895–S896. 4 indexed citations

Yamamoto, Noboru, Judith Raimbourg, Martha Blaney, et al.. (2024). 1257MO ABBV-400, a c-Met protein-targeting antibody-drug conjugate (ADC), in patients (Pts) with advanced EGFR wildtype (WT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase I study. Annals of Oncology. 35. S805–S806. 4 indexed citations

Le, Xiuning, Corinne Maurice‐Dror, Aru Panwar, et al.. (2020). 975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma. Annals of Oncology. 31. S685–S685. 3 indexed citations

Powderly, John D., Toshio Shimizu, Patricia LoRusso, et al.. (2020). 596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours. Annals of Oncology. 31. S499–S499. 2 indexed citations

Schwartzberg, Lee S., Denise A. Yardley, Anthony Elias, et al.. (2017). A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer. Clinical Cancer Research. 23(15). 4046–4054. 42 indexed citations

Schmid, Peter, Ahmad Awada, Hardeep Uppal, et al.. (2015). Stage 1 results from MDV3100-11: A 2-stage study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC). Annals of Oncology. 26. iii6–iii6. 14 indexed citations

Traina, Tiffany A., Joyce O’Shaughnessy, Rita Nanda, et al.. (2015). Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC). Cancer Research. 75(9_Supplement). P5–19. 6 indexed citations

Schwartzberg, Lee S., Denise A. Yardley, Anthony Elias, et al.. (2014). Enzalutamide plus exemestane: A pilot study to assess safety, pharmacokinetics, and effects on circulating estrogens in women with advanced hormone-positive breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 545–545. 4 indexed citations

10.

Traina, Tiffany A., Denise A. Yardley, Manish R. Patel, et al.. (2014). A Phase 1 Open-Label Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enzalutamide Alone or Combined with an Aromatase Inhibitor in Women with Advanced Breast Cancer. Annals of Oncology. 25. i4–i4. 3 indexed citations

11.

Fishbane, Steven, et al.. (2011). Tenecteplase for the improvement of blood flow rate in dysfunctional hemodialysis catheters. Clinical Nephrology. 77(1). 55–61. 4 indexed citations

12.

Tumlin, James A., David Spiegel, Martha Blaney, et al.. (2010). Abstract No. 152: A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3. Journal of Vascular and Interventional Radiology. 21(2). S59–S60. 1 indexed citations

13.

Gabrail, Nashat, Eric Sandler, Veena Charu, et al.. (2010). TROPICS 1: A Phase III, Randomized, Double-blind, Placebo-controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters. Journal of Vascular and Interventional Radiology. 21(12). 1852–1858. 12 indexed citations

14.

Fishbane, Steven, Kenneth D. Lempert, Joachim Hertel, et al.. (2010). Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4. Journal of Thrombosis and Thrombolysis. 31(1). 99–106. 4 indexed citations

15.

Nallamothu, Brahmajee K., Martha Blaney, Lori Parsons, et al.. (2007). Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from 1994-2003. The American Journal of Medicine. 120(8). 693.e1–693.e8. 16 indexed citations

16.

McNamara, Robert L., Jeph Herrin, Yongfei Wang, et al.. (2007). Impact of Delay in Door-to-Needle Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology. 100(8). 1227–1232. 46 indexed citations

17.

Curtis, Jeptha P., Edward L. Portnay, Yongfei Wang, et al.. (2006). The Pre-Hospital Electrocardiogram and Time to Reperfusion in Patients With Acute Myocardial Infarction, 2000–2002. Journal of the American College of Cardiology. 47(8). 1544–1552. 158 indexed citations

18.

McNamara, Robert L., Yongfei Wang, Jeph Herrin, et al.. (2006). Effect of Door-to-Balloon Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 47(11). 2180–2186. 589 indexed citations breakdown →

19.

McNamara, Robert L., Jeph Herrin, Elizabeth H. Bradley, et al.. (2005). Hospital Improvement in Time to Reperfusion in Patients With Acute Myocardial Infarction, 1999 to 2002. Journal of the American College of Cardiology. 47(1). 45–51. 166 indexed citations

20.

Bradley, Elizabeth H., Sarah A. Roumanis, Martha J. Radford, et al.. (2005). Achieving Door-to-Balloon Times That Meet Quality Guidelines. Journal of the American College of Cardiology. 46(7). 1236–1241. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact